Results 51 to 60 of about 3,216 (177)

A Multi‐Scale Computational Framework for Evaluating Wireless Neuromodulation Feasibility via Magnetoelectric Nanoparticles

open access: yesAdvanced Science, EarlyView.
A multiscale computational framework links single‐nanoparticle magnetoelectric behavior to tissue‐level electric field distributions, integrating experimental data from nanoparticle characterization and in vitro stimulation setups. Applied to a cortical slice configuration, the framework predicts optimal MENP concentrations and stimulation parameters ...
Marta Bonato   +10 more
wiley   +1 more source

Targeted Mechanogenetics to Modulate Specific Deep Neural Circuits

open access: yesAdvanced Science, EarlyView.
This study introduces mechanogenetics, a nanobubble‐enhanced sonogenetic strategy for selective modulation of feeding‐related neural circuits in the mouse lateral hypothalamus. Mechanogenetic stimulation modulates feeding behavior through glutamatergic projections from the lateral hypothalamus to the ventral tegmental area, highlighting its potential ...
Xuandi Hou   +3 more
wiley   +1 more source

The Efficacy, Safety, and Outcomes of Brain‐responsive Neurostimulation (RNS® System) therapy in older adults

open access: yesEpilepsia Open, 2021
Objectives The gold standard for the management of drug‐resistant focal epilepsy (DRE) is resection of epileptogenic zone. However, some patients may not be candidates for resection.
Ifrah Zawar   +5 more
doaj   +1 more source

Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy

open access: yesFrontiers in Pain Research, 2022
Epilepsy is a neurological disorder that affects more than 70 million people globally. A considerable proportion of epilepsy is resistant to anti-epileptic drugs (AED).
Mohamed Abouelleil   +2 more
doaj   +1 more source

Responsive neurostimulation for the treatment of medically intractable epilepsy

open access: yesBrain Research Bulletin, 2013
With an annual incidence of 50/100,000 people, nearly 1% of the population suffers from epilepsy. Treatment with antiepileptic medication fails to achieve seizure remission in 20-30% of patients. One treatment option for refractory epilepsy patients who would not otherwise be surgical candidates is electrical stimulation of the brain, which is a ...
Chong, Liu   +7 more
openaire   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Pilot data on responsive epilepsy neurostimulation, measures of sleep apnea and continuous glucose measurements

open access: yesEpilepsy and Behavior Case Reports, 2018
Objectives: To match responsive neurostimulator (RNS) and polysomnographic data to determine if RNS detections and stimulations correlate with measurements of sleep disordered breathing and continuous glucose measurements (CGM). Materials and methods: In
Katie M. Kinnear   +3 more
doaj   +1 more source

Responsive neurostimulation in pediatric patients with drug-resistant epilepsy

open access: yesNeurosurgical Focus, 2022
OBJECTIVE Medically refractory epilepsy remains a therapeutic challenge when resective surgery is not a practical option and indirect neurostimulation efficacy may be limited. In these instances responsive neurostimulation (RNS) has been used in adults, with good outcomes in most patients.
Nicole, Falls   +2 more
openaire   +2 more sources

Clinical trial barriers in neurostimulation for pediatric drug‐resistant epilepsy

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective The NeuroPace responsive neurostimulation (RNS) System effectively treats focal drug‐resistant epilepsy (DRE) in adults but lacks pediatric regulatory approval. Despite effective off‐label pediatric use, systemic device‐trial challenges have impeded label expansion.
Mira C. Hasner   +15 more
wiley   +1 more source

Evidence for long memory in focal seizure duration

open access: yesEpilepsia Open, 2021
Objective A major source of disability for people with epilepsy involves uncertainty surrounding seizure timing and severity. Although patients often report that long seizure‐free intervals are followed by more severe seizures, there is little ...
Joline M. Fan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy